Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
185
-
Total 13F shares, excl. options
-
60.7M
-
Shares change
-
+2.83M
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$141M
-
Put/Call ratio
-
0.33
-
Number of buys
-
98
-
Number of sells
-
-86
-
Price
-
$23.81
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q4 2022
240 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q4 2022.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.7M shares
.
Largest 10 shareholders include ARK Investment Management LLC (6.7M shares), BlackRock Inc. (5.49M shares), VANGUARD GROUP INC (5.23M shares), STATE STREET CORP (4.43M shares), JPMORGAN CHASE & CO (3.9M shares), FMR LLC (3.09M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.93M shares), Nikko Asset Management Americas, Inc. (2.93M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.04M shares), and Voya Investment Management LLC (1.57M shares).
This table shows the top 185 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.